4processed
Form 4 — Insider Transaction
Enliven Therapeutics, Inc.(ELVN)
Filing Date
June 17, 2026
Accepted
June 17, 2026
Accession No.
0001882764-26-000005
CIK
0001672619
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Other | 6.0K | $2.48 | — | 57.0K | Common Stock | Jun 17, 2026 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Other | 1.4K | $42.785 | — | 55.6K | Common Stock | Jun 17, 2026 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Other | 3.4K | $43.863 | — | 52.2K | Common Stock | Jun 17, 2026 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Other | 1.2K | $44.748 | — | 51.0K | Common Stock | Jun 17, 2026 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Other | 6.0K | $0 | — | 86.0K | Stock Option (right to buy) | Jun 17, 2026 |